The therapeutic effect of bromocriptine in combination with spironolactone in patients with primary aldosteronism: a hypothesis generating pilot study.

Oncotarget · 2017 · PMC5652803 · PMID 29100412

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

borderline significancep= 0.09so close (0.05 < p ≤ 0.1)

However, urine ald / creatinine level at 6 month was with a borderline significance with the MCP test results (p= 0.09).

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.